Biotech's perfect storm.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 19665960.
- Also identified by DOI 10.1016/j.cell.2009.07.026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The global financial crisis has hit biotech companies hard both in the US and Europe as venture capital dries up. Finding new sources of long-term financing for translating research into new therapeutics will be essential for maintaining innovation and new drug development by biotech companies.
Medical subject headings
- Biotechnology